Literature DB >> 2941517

B cell-stimulatory factor 1 (BSF-1) promotes growth of helper T cell lines.

R Fernandez-Botran, P H Krammer, T Diamantstein, J W Uhr, E S Vitetta.   

Abstract

T cell-derived supernatants (SN) that contain B cell-stimulatory factor 1 (BSF-1) and lack IL-2 promote the growth of the IL-2-dependent T cell line, HT-2, as well as three other clones or lines of T cells that can provide help to B cells. The BSF-1 purified from these SNs promotes growth of HT-2 cells approximately 50% as effectively as purified IL-2. A potential involvement for contaminating IL-2 in the BSF-1 preparations was excluded by the demonstration that anti-BSF-1 mAbs blocked the BSF-1-induced growth of HT-2 cells; in contrast, these antibodies did not block the IL-2-induced proliferation of the HT-2 cells. In addition, anti-IL-2 mAbs or anti-IL-2-R antibodies blocked the HT-2 growth-promoting activity of purified IL-2, but not BSF-1. Finally, BSF-1 promoted only a very modest growth of Con A-induced T cell blasts, and failed to induce significant growth in seven other cytotoxic, alloreactive, and long-term T cell lines. Taken together, these results indicate that in addition to its known effects on resting and LPS-stimulated B cells, BSF-1 can promote growth of certain subsets of activated T cells, in particular, those that provide help to B cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2941517      PMCID: PMC2188229          DOI: 10.1084/jem.164.2.580

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  38 in total

1.  A simplified method for cyanogen bromide activation of agarose for affinity chromatography.

Authors:  S C March; I Parikh; P Cuatrecasas
Journal:  Anal Biochem       Date:  1974-07       Impact factor: 3.365

2.  The murine B cell response to TNP-polyacrylamide beads: the relationship between the epitope density of the antigen and the requirements for T cell help and surface IgD.

Authors:  E Puré; E S Vitetta
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

3.  Small and large B cells respond differently to T cell-derived B cell growth and differentiation factors.

Authors:  J E Layton; P H Krammer; T Hamaoka; J W Uhr; E S Vitetta
Journal:  J Mol Cell Immunol       Date:  1985

4.  Identification of a T cell-derived b cell growth factor distinct from interleukin 2.

Authors:  M Howard; J Farrar; M Hilfiker; B Johnson; K Takatsu; T Hamaoka; W E Paul
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

5.  Thymoma production of T cell growth factor (Interleukin 2).

Authors:  J J Farrar; J Fuller-Farrar; P L Simon; M L Hilfiker; B M Stadler; W L Farrar
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

6.  Culture supernatants of a stimulated T-cell line have helper activity that acts synergistically with interleukin 2 in the response of B cells to antigen.

Authors:  S L Swain; G Dennert; J F Warner; R W Dutton
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

7.  Continuous proliferation of murine antigen-specific helper T lymphocytes in culture.

Authors:  J Watson
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

8.  Biochemical and biological characterization of lymphocyte regulatory molecules. I. Purification of a class of murine lymphokines.

Authors:  J Watson; S Gillis; J Marbrook; D Mochizuki; K A Smith
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

9.  T cell-derived B cell differentiation factor(s). Effect on the isotype switch of murine B cells.

Authors:  P C Isakson; E Puré; E S Vitetta; P H Krammer
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

10.  Antigen-reactive T cell clones. I. Transcomplementing hybrid I-A-region gene products function effectively in antigen presentation.

Authors:  M Kimoto; C G Fathman
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

View more
  39 in total

1.  Regulation by glutathione of interleukin-4 activity on cytotoxic T cells.

Authors:  S M Liang; N Lee; D S Finbloom; C M Liang
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

2.  Evidence of a plasma-mediated "window" of immunodeficiency in rats following trauma.

Authors:  C D Mills; M D Caldwell; D S Gann
Journal:  J Clin Immunol       Date:  1989-03       Impact factor: 8.317

Review 3.  History of interleukin-4.

Authors:  William E Paul
Journal:  Cytokine       Date:  2015-03-23       Impact factor: 3.861

4.  Cross-linking of interleukin 4 to surface molecules on murine T and B lymphocytes.

Authors:  R Fernandez-Botran; J W Uhr; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

5.  B cell growth factor activity in supernatants of MRL-lpr/lpr derived T cell hybridomas.

Authors:  U Schauer
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

6.  Interleukin 4 mediates autocrine growth of helper T cells after antigenic stimulation.

Authors:  R Fernandez-Botran; V M Sanders; K G Oliver; Y W Chen; P H Krammer; J W Uhr; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

7.  Endogenously secreted IL-4 is required for mouse thymocytes to become cytotoxic. Human, but not mouse, IL-2 induces a functionally immature thymic subset to secrete IL-4 and become CTL.

Authors:  K E Stedman; L B Justement; P A Campbell
Journal:  Immunology       Date:  1990-08       Impact factor: 7.397

8.  Interleukin 4 is important in protective immunity to a gastrointestinal nematode infection in mice.

Authors:  J F Urban; I M Katona; W E Paul; F D Finkelman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

9.  Gangliosides interact with interleukin-4 and inhibit interleukin-4-stimulated helper T-cell proliferation.

Authors:  J W Chu; F J Sharom
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

10.  Glycosylation variants of murine interleukin-4: evidence for different functional properties.

Authors:  G Thor; A A Brian
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.